There is a technology now available called microencapsulation
[1] [2] For diabetes, it's marketed as Ozempic (injectable, up to 2 mg weekly) and Rybelsus (oral, 7-14 mg daily)
Like metformin, acarbose is effective as a first-line drug for type 2 diabetes insufficiently controlled by diet alone, and does not stimulate insulin secretion or cause hypoglycemia or weight gain
No control group - There was no comparison group receiving standard GLP-1 dosing without the IVIM protocol, so you can't isolate which specific elements of the program drove the results
Compounded tirzepatide, which contains the same active ingredient, usually costs less
Now that Foundayo has been approved by the FDA, prescriptions will start shipping April 6 from LillyDirect (Lillys direct-to-consumer pharmacy service)